Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | cytochrome b | 0.0575 | 0.5 | 0.5 |
Plasmodium falciparum | cytochrome b | 0.0575 | 0.5 | 0.5 |
Schistosoma mansoni | cytochrome b | 0.0575 | 0.5 | 0.5 |
Toxoplasma gondii | apocytochrome b, putative | 0.0575 | 0.5 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | cytochrome b subunit of the bc complex | 0.0575 | 0.5 | 0.5 |
Loa Loa (eye worm) | cytochrome b | 0.0575 | 0.5 | 0.5 |
Plasmodium vivax | cytochrome b | 0.0575 | 0.5 | 0.5 |
Echinococcus granulosus | cytochrome B | 0.0575 | 0.5 | 0.5 |
Toxoplasma gondii | cytochrome b | 0.0575 | 0.5 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | = 0 uM | Inhibition of PMA and [Ca2+] induced 32P incorporation into histones by partially purified rat brain Protein kinase C - Agonist | ChEMBL. | 1895309 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.